nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Biomarkers of cancer metastasis through the lymphovascular system: future perspectives
|
Leong, Stanley P. L. |
|
2012 |
29 |
7 |
p. 861-864 |
artikel |
2 |
Clinically relevant biomarkers in targeted radiotherapy
|
Stea, Baldassarre |
|
2012 |
29 |
7 |
p. 853-860 |
artikel |
3 |
Dividing and conquering: controlling advanced melanoma by targeting oncogene-defined subsets
|
Flaherty, Keith T. |
|
2012 |
29 |
7 |
p. 841-846 |
artikel |
4 |
Editorial
|
Leong, Stanley P. L. |
|
2012 |
29 |
7 |
p. 639-640 |
artikel |
5 |
Epigenetics of regional lymph node metastasis in solid tumors
|
Huynh, Kelly T. |
|
2012 |
29 |
7 |
p. 747-756 |
artikel |
6 |
Erratum to: Progression of cutaneous melanoma: implications for treatment
|
Leong, Stanley P. L. |
|
2012 |
29 |
7 |
p. 797-799 |
artikel |
7 |
Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets
|
Nagy, Janice A. |
|
2012 |
29 |
7 |
p. 657-662 |
artikel |
8 |
Immuno-SPET/CT and immuno-PET/CT: a step ahead to translational imaging
|
Pecking, Alain P. |
|
2012 |
29 |
7 |
p. 847-852 |
artikel |
9 |
Lymphatics, lymph nodes and the immune system: barriers and gateways for cancer spread
|
Ferris, Robert L. |
|
2012 |
29 |
7 |
p. 729-736 |
artikel |
10 |
Meeting the biologic challenge of colorectal metastases
|
Wanebo, Harold J. |
|
2012 |
29 |
7 |
p. 821-839 |
artikel |
11 |
Molecular profiling for personalized cancer care
|
Ashfaq, Raheela |
|
2012 |
29 |
7 |
p. 653-655 |
artikel |
12 |
Overlapping biomarkers, pathways, processes and syndromes in lymphatic development, growth and neoplasia
|
Witte, Marlys H. |
|
2012 |
29 |
7 |
p. 707-727 |
artikel |
13 |
Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma
|
Morton, Donald L. |
|
2012 |
29 |
7 |
p. 699-706 |
artikel |
14 |
Preoperative sentinel lymph node mapping of the prostate using PET/CT fusion imaging and Ga-68-labeled tilmanocept in an animal model
|
Stroup, Sean P. |
|
2012 |
29 |
7 |
p. 673-680 |
artikel |
15 |
Progression of cutaneous melanoma: implications for treatment
|
Leong, Stanley P. L. |
|
2012 |
29 |
7 |
p. 775-796 |
artikel |
16 |
Reduction of circulating regulatory T cells by intravenous high-dose interferon alfa-2b treatment in melanoma patients
|
Mozzillo, Nicola |
|
2012 |
29 |
7 |
p. 801-805 |
artikel |
17 |
Rigorous quantitative sciences integration—the foundation of high-dimensional genomic research
|
Shyr, Yu |
|
2012 |
29 |
7 |
p. 641-643 |
artikel |
18 |
Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread?
|
Pennacchioli, Elisabetta |
|
2012 |
29 |
7 |
p. 757-773 |
artikel |
19 |
Sentinel lymph node biopsy versus selective neck dissection for detection of metastatic oral squamous cell carcinoma
|
Ferris, Robert L. |
|
2012 |
29 |
7 |
p. 693-698 |
artikel |
20 |
Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer?
|
Giuliano, Armando E. |
|
2012 |
29 |
7 |
p. 687-692 |
artikel |
21 |
Stromal biomarkers in breast cancer development and progression
|
Rudnick, Jenny A. |
|
2012 |
29 |
7 |
p. 663-672 |
artikel |
22 |
Systematic, evidence-based discovery of biomarkers at the NCI
|
Prensner, John R. |
|
2012 |
29 |
7 |
p. 645-652 |
artikel |
23 |
The connectivity of lymphogenous and hematogenous tumor cell dissemination: biological insights and clinical implications
|
Sleeman, Jonathan P. |
|
2012 |
29 |
7 |
p. 737-746 |
artikel |
24 |
The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the 99mTc-labeled nanocolloid human serum albumin standard of care
|
Tokin, Christopher A. |
|
2012 |
29 |
7 |
p. 681-686 |
artikel |
25 |
The role of targeted therapy and biomarkers in breast cancer treatment
|
Stopeck, Alison T. |
|
2012 |
29 |
7 |
p. 807-819 |
artikel |